Return to homepagePandemic Pact

ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSI

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N95022C00032-0-9999-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2025

  • Known Financial Commitments (USD)

    $2,701,936

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    SANDRA BUTLER

  • Research Location

    United States of America

  • Lead Research Institution

    TECHNICAL RESOURCES INTERNATIONAL, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase III

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

CRO Assistance for Long-term Storage, Distribution and Analysis of Biospecimens from the ACTIV-1 Master Protocol, an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.